Immunodeficiency Clinical Trial
Official title:
Use of UV-treated Milk Powder to Increase Vaccine Efficacy in the Elderly
Aging populations experience a decline in adaptive immune system function also known as immunosenesence. Nutritional approaches to stimulate and strengthen the immune system are needed for this growing segment of the population. A controlled, randomized, double blind pilot study was conducted using two different protein sources as nutritional supplementation to enhance vaccine response. Our objective was to examine the immune stimulating effects of dairy protein subjected to ultraviolet radiation (UV-C) radiation treatment process instead of pasteurization. Participants were 21 healthy individuals over 60 years of age who consumed 6 g of the dairy protein or a comparison, soy isoflavone protein, twice a day for eight weeks. DTaP vaccine administered at week 4. Non-parametric t-tests revealed a significant increase in Tetanus antibodies in the dairy group compared to the soy group at week 8. These findings suggest additional benefits of UV-C treated unheated dairy protein as a solution to counteract immunosenescence, but warrant further study in elderly and other populations that might benefit from immune system stimulation.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02651376 -
Safety and Efficacy of Allogenic Adoptive Immune Therapy for Advanced AIDS Patients
|
Phase 1/Phase 2 | |
| Completed |
NCT02345135 -
Susceptibility to Infections in Ataxia Telangiectasia
|
N/A | |
| Completed |
NCT04553705 -
Omega-3, Nigella Sativa, Indian Costus, Quinine, Anise Seed, Deglycyrrhizinated Licorice, Artemisinin, Febrifugine on Immunity of Patients With (COVID-19)
|
Phase 2/Phase 3 | |
| Completed |
NCT00758992 -
Peripheral Blood Stem Cells Obtained From Normal Volunteers for Studying Retroviral Vector Mediated Gene Transfer Into Primitive Hematopoietic Cells and Vector Mediated Transgene Expression in Mature Hematopoietic Lineages
|
N/A | |
| Recruiting |
NCT05907746 -
Allogeneic Hematopoietic Stem Cell Transplantation With JSP191-Based Conditioning in Participants With GATA2 Deficiency
|
Phase 2 | |
| Active, not recruiting |
NCT02291965 -
Blood Samples to Identify Biomarkers of Busulfan
|
||
| Recruiting |
NCT04408950 -
Sample Collection for Systems Evaluation of Patients With Unknown or Incompletely Characterized Immune Defects
|
||
| Completed |
NCT00923364 -
Pilot and Feasibility Study of Reduced-Intensity Hematopoietic Stem Cell Transplant for MonoMAC
|
Phase 2 | |
| Withdrawn |
NCT05672654 -
Evaluation of Post-SARS-CoV-2 Vaccinal Response in Immunocompromised Patients
|
N/A | |
| Recruiting |
NCT05405491 -
Impact of a Strategy Based on Bacterial DNA Detection to Optimize Antibiotics in Immunocompromised Patients With Hospital-acquired Pneumonia Requiring Mechanical Ventilation
|
N/A | |
| Recruiting |
NCT01800643 -
Evaluation of Plasmatic Levels of Busulfan in Patients Undergoing Hematopoietic Stem Cell Transplantation
|
Phase 2/Phase 3 | |
| Recruiting |
NCT00001467 -
Genetic Analysis of Immune Disorders
|
||
| Not yet recruiting |
NCT04447937 -
Immunodeficiency in MS
|
||
| Completed |
NCT00925925 -
Epigenetic Markers of B-Cell Function in Low Birth Weight Infants
|
N/A | |
| Recruiting |
NCT01861106 -
Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations
|
Phase 2 | |
| Recruiting |
NCT06248957 -
SYSTEMS-LEVEL ANALYSES OF IMMUNE DYSREGULATION
|
||
| Suspended |
NCT05027945 -
A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome
|
Phase 2 | |
| Active, not recruiting |
NCT05655546 -
ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals
|
N/A | |
| Completed |
NCT03374566 -
Immunodeficiency for Severe Epstein-Barr Virus Infection
|
||
| Terminated |
NCT01027702 -
Donor Lymphocyte Infusion After Alternative Donor Transplantation
|
Phase 1/Phase 2 |